An organization funding research on extending the human life span by preventing age-related diseases is founding its first biotechnology company. . . . → Read More: Longevity Science Group Spins-Off Biotech Start-Up
|
|||||
       |
A developer of therapies addressing the body’s microbe communities is selling off key assets to another biotechnology company, after problems developed with its lead program. . . . → Read More: Collapsed Microbiome Biotech Sells Off Assets  Comments are closed  Intellectual property, New products  biomedical, biotechnology, cancer, clinical trials, engineering, entrepreneurs, licensing, life sciences, manufacturing, mathematics, pharmaceuticals, university 
A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs. . . . → Read More: FDA Funds Study of Real World Data for Biosimilars Comments are closed Finance, Regulations biomedical, FDA, grant, health care, mathematics, pharmaceuticals, software 
A developer of treatments for Alzheimer’s disease that seeks to improve the condition of the brain’s support cells is raising £48 million ($US 61 million) in its first venture round. . . . → Read More: Neuro Disease Biotech Gains $61M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, licensing, life sciences, pharmaceuticals, physical sciences, U.K., university, venture capital 
A biotechnology company is receiving NIH support for discovering antibodies that address the vast majority of proteins coded by the human genome, passed-up so far by drug makers. . . . → Read More: NIH Funds Antibody Discovery for Difficult Protein Targets Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, genomics, grant, life sciences, NIH, pharmaceuticals, physical sciences, preclinical 
Research with lab mice shows an experimental vaccine stimulates the body’s basic immune system to protect against a range of pathogens associated with hospital infections. . . . → Read More: Vaccine Shown to Protect Against Multiple Hospital Pathogens Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, grant, health care, licensing, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K. . . . → Read More: Industry-Academic Center to Boost Rare Disease Therapies Comments are closed Finance, Joint ventures/collaborations biomedical, biotechnology, cancer, genomics, grant, investment, life sciences, pharmaceuticals, U.K., university, venture capital 
The Nasdaq Biotechnology Index, an indicator of investor sentiment in an industry based on science, continued heading down during the third quarter of 2023. . . . → Read More: Infographic – Biotech Index Continues Downward Trend 
A company with a process to generate new thymus tissue for immune system functions is receiving a $37 million award from the government’s health breakthrough agency. . . . → Read More: Biotech Thymus Tissue Process Gains ARPA-H Funding Comments are closed Finance, New products biomedical, biotechnology, contract, entrepreneurs, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, stem cells, university 
Initial results from a clinical trial show an experimental vaccine produces immune responses in healthy adults against Covid-19 variants and a range of other coronaviruses. . . . → Read More: Trial Shows Broad Coronavirus Immune Response Comments are closed New products biomedical, biotechnology, Canada, clinical trials, Covid-19, health care, life sciences, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts